GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (FRA:0YX) » Definitions » Debt-to-EBITDA

Sysmex (FRA:0YX) Debt-to-EBITDA : 0.45 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Sysmex Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sysmex's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €50 Mil. Sysmex's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €269 Mil. Sysmex's annualized EBITDA for the quarter that ended in Dec. 2023 was €703 Mil. Sysmex's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.45.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sysmex's Debt-to-EBITDA or its related term are showing as below:

FRA:0YX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.03   Med: 0.24   Max: 0.48
Current: 0.48

During the past 13 years, the highest Debt-to-EBITDA Ratio of Sysmex was 0.48. The lowest was 0.03. And the median was 0.24.

FRA:0YX's Debt-to-EBITDA is ranked better than
69.37% of 431 companies
in the Medical Devices & Instruments industry
Industry Median: 1.25 vs FRA:0YX: 0.48

Sysmex Debt-to-EBITDA Historical Data

The historical data trend for Sysmex's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Debt-to-EBITDA Chart

Sysmex Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.30 0.30 0.24 0.22

Sysmex Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.22 0.29 0.22 0.45

Competitive Comparison of Sysmex's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Sysmex's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sysmex's Debt-to-EBITDA falls into.



Sysmex Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sysmex's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(49.955 + 107.903) / 713.342
=0.22

Sysmex's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(49.989 + 268.716) / 702.588
=0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Sysmex  (FRA:0YX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Sysmex Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sysmex's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex (FRA:0YX) Business Description

Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (FRA:0YX) Headlines

No Headlines